Most tumors, which would have been classified as ETS negative based on the exclusive assessment of the few ETS genes known to be translocated in prostate tumors (i.e., ERG, ETV1 and ETV4) had in fact significantly alterations of other ETS factors. This evidence concerns the gene ERG and prostate neoplasm.